{"disease":{"id":"migraine-prophylaxis","name":"migraine prophylaxis"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03308968","title":"An Efficacy and Safety Study of Fremanezumab in Adults With Migraine","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":838,"lead_sponsor_name":"Teva Branded Pharmaceutical Products R&D, Inc.","has_results":true},{"nct_id":"NCT06136442","title":"Atogepant in Real Life in Italy (GIANT)","phase":"","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"IRCCS San Raffaele Roma","has_results":false},{"nct_id":"NCT06728345","title":"The Real-world Study of Rimegepant Treatment in Female Migraine Patients of China","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":300,"lead_sponsor_name":"The First Affiliated Hospital of Soochow University","has_results":false},{"nct_id":"NCT05846373","title":"Effect of Nicotinic Acid as Add on Therapy in Patients Receiving β Blocker for Prophylaxis of Moderate to Severe Migraine","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":58,"lead_sponsor_name":"Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}